Latest On InspireMD, Inc (NSPR):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-16 17:01 EST | News | InspireMD GAAP EPS of -$0.53 beats by $0.15, revenue of $1.24M beats by $0.24M | N/A |  |
| 2023-05-16 17:01 EST | News | InspireMD, Inc. (NSPR) Q1 2023 Earnings Call Transcript | N/A | |
| 2023-05-15 13:06 EST | News | InspireMD to raise $113.6M via private placement | N/A | |
| 2023-03-31 08:16 EST | News | InspireMD, Inc. (NSPR) Q4 2022 Earnings Call Transcript | N/A | |
| 2023-03-30 08:08 EST | News | InspireMD GAAP EPS of $0.60 beats by $1.44, revenue of $1.03M beats by $0.03M | N/A | |
About InspireMD, Inc (NSPR):
InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia. The company offers CGuard carotid embolic prevention system for use in carotid artery applications; and MGuard Prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions. It is also developing NGuard, a neurovascular flow diverter that diverts blood flow away from cerebral aneurysms and seals the aneurysms. The company sells its products through local distributors. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv, Israe read more...l.
General
- Name InspireMD, Inc
- Symbol NSPR
- Type Common Stock
- Exchange NYSE MKT
- Currency USD
- Country USA
- SectorHealthcare
- IndustryMedical Devices
- Full Time Employees 45
- Last Split Factor1:50
- Last Split Date2019-04-01
- Fiscal Year EndDecember
- IPO Date2011-04-12
- Gic SectorHealth Care
- Gic GroupHealth Care Equipment & Services
- Gic IndustryHealth Care Equipment & Supplies
- Gic SubIndustryHealth Care Supplies
- Web URLhttp://www.inspiremd.com
Valuation
- Trailing PE 0.59
- Forward PE 11.7
- Price/Sales (Trailing 12 Mt.) 6.66
- Price/Book (Most Recent Quarter) 7.07
- Enterprise Value Revenue 29.92
- Enterprise Value EBITDA 0.18
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$0.19
- Next Year EPS Estimate -$0.17
- Next Quarter EPS Estimate -$0.08
- Operating Margin -400%
- Return on Assets -45%
- Return on Equity -120%
- Revenue 2.49 million
- Earnings Per Share -$9.91
- Revenue Per Share $0.11
- Gross Profit 83000
- Quarterly Earnings Growth -84.4%
Highlights
- Market Capitalization 98.15 million
- EBITDA -9352000
- Analyst Target Price $1.02
- Book Value Per Share $0.25
Share Statistics
- Shares Outstanding 117.83 million
- Shares Float 108.09 million
- % Held by Insiders 1203%
- % Held by Institutions 2.82%
- Shares Short 3.6 million
- Shares Short Prior Month 2.57 million
- Short Ratio 0.12
- Short % of Float 3%
- Short % of Shares Outstanding 3%
Technicals
- Beta 2.13
- 52 Week High $1.48
- 52 Week Low $0.28
- 50 Day Moving Average 0.9
- 200 Day Moving Average 0.52
Dividends
- Dividend Date 2019-04-01
- ExDividend Date N/A
- Dividend Yield 0%
InspireMD, Inc (NSPR) Dividend Calendar:
NSPR's last dividend payment was made to shareholders on April 1, 2019.
InspireMD, Inc (NSPR) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
InspireMD, Inc (NSPR) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
InspireMD, Inc (NSPR) Chart:
InspireMD, Inc (NSPR) News:
Below you will find a list of latest news for InspireMD, Inc (NSPR) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
InspireMD, Inc (NSPR) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
Latest NSPR Trades:
InspireMD, Inc (NSPR) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | View |
|---|---|---|
| 2020-11-03 | 8-K (Current report) | |
| 2020-10-19 | 8-K (Current report) | |
| 2020-10-19 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-10-16 | 3 (Initial statement of beneficial ownership of securities) | |
| 2020-10-16 | 8-K (Current report) | |
| 2020-10-06 | 8-K (Current report) | |
| 2020-10-05 | S-8 (Securities to be offered to employees in employee benefit plans) | |
| 2020-09-16 | S-8 (Securities to be offered to employees in employee benefit plans) | |
| 2020-09-08 | 8-K (Current report) | |
| 2020-09-03 | 8-K (Current report) | |
| 2020-09-02 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-09-02 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-09-02 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-09-02 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-09-02 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-09-02 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-08-31 | 8-K (Current report) | |
| 2020-08-18 | 8-K (Current report) | |
| 2020-08-10 | 8-K (Current report) | |
| 2020-08-05 | 8-K (Current report) | |
InspireMD, Inc (NSPR) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of InspireMD, Inc (NSPR). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 1203%
Institutional Ownership: 282%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2020-10-16 | GARY S ROUBIN | Director | Buy | 222,223.00 | 0.45 | 100,000.35 | 461,173.00 | |
| 2020-08-31 | Marvin Slosman | CEO and President | Buy | 1,175,287.00 | 1,413,218.00 | | ||
| 2020-08-31 | Campbell Rogers | Director | Buy | 158,033.00 | 160,635.00 | | ||
| 2020-08-31 | MICHAEL BERMAN | Director | Buy | 158,033.00 | 160,635.00 | | ||
| 2020-08-31 | Thomas J Kester | Director | Buy | 158,033.00 | 210,633.00 | | ||
| 2020-08-31 | Paul Stuka | Director | Buy | 238,950.00 | 243,606.00 | | ||
| 2020-08-31 | Craig Shore | CFO AND CAO | Buy | 678,834.00 | 684,849.00 | | ||
| 2020-06-05 | Marvin Slosman | CEO and President | Buy | 55,550.00 | 0.45 | 24,997.50 | 237,931.00 | |
| 2020-06-03 | Thomas J Kester | Director | Buy | 50,000.00 | 0.42 | 20,750.00 | 52,600.00 | |
| 2020-01-02 | Marvin Slosman | CEO and President | Buy | 182,381.00 | 182,381.00 | | ||
| 2019-12-16 | James J Barry | President and CEO | Buy | 165,000.00 | 2,166,382.00 | | ||
| 2019-02-04 | Thomas J Kester | Director | Buy | 130,000.00 | 130,000.00 | | ||
| 2019-02-04 | MICHAEL BERMAN | Director | Buy | 130,000.00 | 130,005.00 | | ||
| 2019-02-04 | Campbell Rogers | Director | Buy | 130,000.00 | 130,011.00 | | ||
| 2019-02-04 | James J Barry | President and CEO | Buy | 2,000,000.00 | 2,001,382.00 | | ||
| 2019-02-04 | Paul Stuka | Director | Buy | 195,000.00 | 219,999.00 | | ||
| 2019-02-04 | Craig Shore | CFO AND CAO | Buy | 300,000.00 | 300,532.00 | | ||
| 2018-12-11 | Paul Stuka | Director | Sell | 65.00 | 0.18 | 11.54 | 12,746.00 | |
| 2018-11-21 | Thomas J Kester | Director | Sell | 8.00 | 0.21 | 1.68 | 0.00 | |